Related Experiment Video

Updated: Mar 20, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.8K

The present and the future of the RAS pathway: From function and genomics to inhibition

Ignacio Gil-Bazo1, Alejandro Sweet-Cordero2, Silvestre Vicent3

  • 1a Department of Medical Oncology , Clínica Universidad de Navarra , Pamplona , Spain.

Cancer Biology & Therapy
|May 24, 2016
PubMed

Insights

Scientists convened to discuss the RAS pathway, focusing on its function, genomics, and inhibition. Advances included new mouse models for drug testing and strategies for treating RAS-driven cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RAS pathway is crucial in cell signaling and implicated in various human cancers.
  • Understanding RAS pathway function and genomics is key for developing targeted therapies.

Purpose of the Study:

  • To summarize key findings and discussions from the II International Frontiers in Oncology meeting on the RAS pathway.
  • To highlight recent advances in RAS pathway research, from basic science to clinical applications.

Main Methods:

  • The report synthesizes information presented at the RAS Frontiers meeting.
  • Discussions covered novel mouse models, identification of pathway vulnerabilities, and current therapeutic strategies.

Main Results:

  • Novel mouse models were presented as preclinical platforms for drug testing in human carcinogenesis.
  • Cutting-edge approaches for identifying RAS pathway vulnerabilities and regulators were discussed.
  • Current inhibitory strategies for treating RAS-driven cancers were a significant topic.

Conclusions:

  • The meeting underscored the importance of the RAS pathway in oncology.
  • Advances in understanding and targeting the RAS pathway offer promise for future cancer treatments.
Keywords:
Cancer biologyKRASfunctional genomicsoncologypreclinical modelstherapeutics

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K
Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays14:06

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays

Published on: November 12, 2012

47.1K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.1K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.5K